Currently, there are 204.85M common shares owned by the public and among those 193.02M shares have been available to trade.
The company’s stock has a 5-day price change of -11.26% and 44.78% over the past three months. COIN shares are trading 2.85% year to date (YTD), with the 12-month market performance up to 80.91% higher. It has a 12-month low price of $114.51 and touched a high of $349.75 over the same period. COIN has an average intraday trading volume of 13.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.58%, -9.65%, and 11.19% respectively.
Institutional ownership of Coinbase Global Inc (NASDAQ: COIN) shares accounts for 42.73% of the company’s 204.85M shares outstanding.
It has a market capitalization of $63.93B and a beta (3y monthly) value of 3.59. The stock’s trailing 12-month PE ratio is 43.65, while the earnings-per-share (ttm) stands at $5.85. The company has a debt-to-equity ratio at 0.52. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.20% over the week and 6.04% over the month.
Analysts forecast that Coinbase Global Inc (COIN) will achieve an EPS of 1.58 for the current quarter, 1.38 for the next quarter and 4.73 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.23 while analysts give the company a high EPS estimate of 0.23. Comparatively, EPS for the current quarter was 1.04 a year ago. Earnings per share for the fiscal year are expected to increase by 1626.24%, and -21.59% over the next financial year.
Looking at the support for the COIN, a number of firms have released research notes about the stock. Monness Crespi & Hardt stated their Buy rating for the stock in a research note on December 19, 2024, with the firm’s price target at $245-$390. Oppenheimer coverage for the Coinbase Global Inc (COIN) stock in a research note released on November 25, 2024 offered a Outperform rating with a price target of $358. Monness Crespi & Hardt was of a view on October 28, 2024 that the stock is Buy, while B. Riley Securities gave the stock Neutral rating on October 23, 2024, issuing a price target of $185. Barclays on their part issued Equal Weight rating on September 06, 2024.
